Rank | Gene Set | Z-score |
---|---|---|
1 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.49181374 |
2 | synaptic vesicle exocytosis (GO:0016079) | 5.20248995 |
3 | vocalization behavior (GO:0071625) | 5.17898098 |
4 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.10434826 |
5 | synaptic vesicle maturation (GO:0016188) | 4.97364579 |
6 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.95456325 |
7 | locomotory exploration behavior (GO:0035641) | 4.95055959 |
8 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.84922423 |
9 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.77668202 |
10 | glutamate secretion (GO:0014047) | 4.77370450 |
11 | neuron cell-cell adhesion (GO:0007158) | 4.62963588 |
12 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.59515104 |
13 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.44869805 |
14 | protein localization to synapse (GO:0035418) | 4.44282969 |
15 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.43667703 |
16 | neuronal action potential propagation (GO:0019227) | 4.42686780 |
17 | regulation of synaptic vesicle transport (GO:1902803) | 4.28990363 |
18 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.27126786 |
19 | neurotransmitter secretion (GO:0007269) | 4.24356242 |
20 | exploration behavior (GO:0035640) | 4.17848823 |
21 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.13524015 |
22 | glutamate receptor signaling pathway (GO:0007215) | 4.06448960 |
23 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.04096158 |
24 | neuron-neuron synaptic transmission (GO:0007270) | 3.95061494 |
25 | synaptic transmission, glutamatergic (GO:0035249) | 3.93004195 |
26 | regulation of synapse structural plasticity (GO:0051823) | 3.91553521 |
27 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.75655748 |
28 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.74271957 |
29 | layer formation in cerebral cortex (GO:0021819) | 3.65884477 |
30 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.64687658 |
31 | neuron recognition (GO:0008038) | 3.63599465 |
32 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.61964848 |
33 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.59203466 |
34 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.58034126 |
35 | gamma-aminobutyric acid transport (GO:0015812) | 3.57849041 |
36 | proline transport (GO:0015824) | 3.57234927 |
37 | L-amino acid import (GO:0043092) | 3.56420671 |
38 | regulation of postsynaptic membrane potential (GO:0060078) | 3.51978045 |
39 | activation of protein kinase A activity (GO:0034199) | 3.49731886 |
40 | dendritic spine morphogenesis (GO:0060997) | 3.47647187 |
41 | neuronal ion channel clustering (GO:0045161) | 3.47216454 |
42 | neurotransmitter transport (GO:0006836) | 3.47174002 |
43 | long-term synaptic potentiation (GO:0060291) | 3.46620392 |
44 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.42962237 |
45 | positive regulation of synapse maturation (GO:0090129) | 3.42885532 |
46 | * long-term memory (GO:0007616) | 3.41016821 |
47 | regulation of synaptic plasticity (GO:0048167) | 3.40293916 |
48 | positive regulation of membrane potential (GO:0045838) | 3.37633983 |
49 | cellular potassium ion homeostasis (GO:0030007) | 3.37495337 |
50 | synaptic vesicle endocytosis (GO:0048488) | 3.35430389 |
51 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.32973428 |
52 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.32531510 |
53 | presynaptic membrane assembly (GO:0097105) | 3.32317515 |
54 | amino acid import (GO:0043090) | 3.31048461 |
55 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.29916884 |
56 | transmission of nerve impulse (GO:0019226) | 3.29174609 |
57 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.27608520 |
58 | regulation of vesicle fusion (GO:0031338) | 3.26630565 |
59 | axonal fasciculation (GO:0007413) | 3.25458740 |
60 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.22710113 |
61 | postsynaptic membrane organization (GO:0001941) | 3.21929587 |
62 | regulation of neurotransmitter secretion (GO:0046928) | 3.21823552 |
63 | regulation of neurotransmitter levels (GO:0001505) | 3.21707654 |
64 | response to histamine (GO:0034776) | 3.17654353 |
65 | detection of calcium ion (GO:0005513) | 3.14461249 |
66 | vesicle transport along microtubule (GO:0047496) | 3.12674070 |
67 | presynaptic membrane organization (GO:0097090) | 3.12310456 |
68 | nucleobase catabolic process (GO:0046113) | 3.12061848 |
69 | behavioral fear response (GO:0001662) | 3.10638895 |
70 | behavioral defense response (GO:0002209) | 3.10638895 |
71 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.06989837 |
72 | potassium ion import (GO:0010107) | 3.05015132 |
73 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.04893308 |
74 | mechanosensory behavior (GO:0007638) | 3.04629675 |
75 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.04362230 |
76 | membrane depolarization (GO:0051899) | 3.04143917 |
77 | central nervous system projection neuron axonogenesis (GO:0021952) | 3.03601546 |
78 | membrane depolarization during action potential (GO:0086010) | 3.03490205 |
79 | innervation (GO:0060384) | 3.02731549 |
80 | positive regulation of neurotransmitter transport (GO:0051590) | 3.02553990 |
81 | regulation of neurotransmitter transport (GO:0051588) | 3.00791422 |
82 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.00679887 |
83 | negative regulation of neurotransmitter transport (GO:0051589) | 3.00067684 |
84 | learning (GO:0007612) | 3.00046945 |
85 | fear response (GO:0042596) | 2.99459190 |
86 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.97808689 |
87 | neuromuscular process controlling balance (GO:0050885) | 2.97640760 |
88 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.96519478 |
89 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.95701198 |
90 | positive regulation of synaptic transmission (GO:0050806) | 2.94755449 |
91 | neuromuscular process controlling posture (GO:0050884) | 2.94700642 |
92 | regulation of synaptic transmission, GABAergic (GO:0032228) | 2.94624106 |
93 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.94373379 |
94 | synapse assembly (GO:0007416) | 2.94046815 |
95 | cellular sodium ion homeostasis (GO:0006883) | 2.93557185 |
96 | glycosphingolipid biosynthetic process (GO:0006688) | 2.93035601 |
97 | synaptic transmission (GO:0007268) | 2.92863884 |
98 | behavioral response to cocaine (GO:0048148) | 2.92706861 |
99 | mating behavior (GO:0007617) | 2.92642745 |
100 | neurotransmitter uptake (GO:0001504) | 2.91224282 |
101 | potassium ion homeostasis (GO:0055075) | 2.91163265 |
102 | nerve growth factor signaling pathway (GO:0038180) | 2.90828800 |
103 | response to auditory stimulus (GO:0010996) | 2.90475933 |
104 | auditory behavior (GO:0031223) | 2.89848681 |
105 | regulation of synaptic transmission (GO:0050804) | 2.88763600 |
106 | establishment of nucleus localization (GO:0040023) | 2.88561051 |
107 | prepulse inhibition (GO:0060134) | 2.87463242 |
108 | negative regulation of neurotransmitter secretion (GO:0046929) | 2.87326586 |
109 | dendrite morphogenesis (GO:0048813) | 2.85589352 |
110 | cell communication by electrical coupling (GO:0010644) | 2.85340693 |
111 | regulation of glutamate secretion (GO:0014048) | 2.84549245 |
112 | negative regulation of dendrite morphogenesis (GO:0050774) | 2.84459487 |
113 | striatum development (GO:0021756) | 2.84364573 |
114 | regulation of dendritic spine development (GO:0060998) | 2.84262875 |
115 | membrane hyperpolarization (GO:0060081) | 2.83104769 |
116 | sodium ion export (GO:0071436) | 2.82944156 |
117 | startle response (GO:0001964) | 2.82190592 |
118 | cerebellar granule cell differentiation (GO:0021707) | 2.81772055 |
119 | negative regulation of dendrite development (GO:2000171) | 2.79955735 |
120 | organelle transport along microtubule (GO:0072384) | 2.79907075 |
121 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.79527962 |
122 | establishment of mitochondrion localization (GO:0051654) | 2.78977749 |
123 | regulation of cell communication by electrical coupling (GO:0010649) | 2.78333290 |
124 | cerebral cortex radially oriented cell migration (GO:0021799) | 2.78266667 |
125 | clathrin coat assembly (GO:0048268) | 2.77662189 |
126 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 2.77166626 |
127 | acidic amino acid transport (GO:0015800) | 2.76441734 |
128 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.73914518 |
129 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 2.72169479 |
130 | C4-dicarboxylate transport (GO:0015740) | 2.69134781 |
131 | synaptic vesicle transport (GO:0048489) | 2.67897207 |
132 | establishment of synaptic vesicle localization (GO:0097480) | 2.67897207 |
133 | positive regulation of dendritic spine development (GO:0060999) | 2.67113225 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.87879820 |
2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.80725877 |
3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.12587517 |
4 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.05902085 |
5 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.96193709 |
6 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.63751708 |
7 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.62364314 |
8 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.62364314 |
9 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.61922133 |
10 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.54100647 |
11 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.51566027 |
12 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.46832142 |
13 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.45860264 |
14 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.44274259 |
15 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.42928196 |
16 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.40328512 |
17 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.24700176 |
18 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.24594278 |
19 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.11670371 |
20 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.10841809 |
21 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.10817122 |
22 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.10162255 |
23 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.05224424 |
24 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.99408539 |
25 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.98618540 |
26 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.95547907 |
27 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.87567531 |
28 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.86689741 |
29 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.86614421 |
30 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.86256635 |
31 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.83832018 |
32 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.79262538 |
33 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.70777527 |
34 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.66950260 |
35 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.66233265 |
36 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.64597372 |
37 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.63781297 |
38 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.59613288 |
39 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.57376470 |
40 | P300_19829295_ChIP-Seq_ESCs_Human | 1.57024974 |
41 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.56704062 |
42 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.54525492 |
43 | * NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.47006285 |
44 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.43543693 |
45 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.40809967 |
46 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.40293453 |
47 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.39608809 |
48 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.38518335 |
49 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.36919699 |
50 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.36792186 |
51 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.35349194 |
52 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.35141446 |
53 | AR_25329375_ChIP-Seq_VCAP_Human | 1.34640381 |
54 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.34087172 |
55 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.33583141 |
56 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.32940022 |
57 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.32898806 |
58 | * NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.32061390 |
59 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.32061390 |
60 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.31875467 |
61 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.31825916 |
62 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.30510796 |
63 | STAT3_23295773_ChIP-Seq_U87_Human | 1.29516879 |
64 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.28326610 |
65 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.26759007 |
66 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.26673020 |
67 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.23969752 |
68 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.22316639 |
69 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.21066606 |
70 | FUS_26573619_Chip-Seq_HEK293_Human | 1.19785359 |
71 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.19319792 |
72 | * AR_19668381_ChIP-Seq_PC3_Human | 1.17730929 |
73 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.17061733 |
74 | * TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.15420012 |
75 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.15410375 |
76 | TCF4_23295773_ChIP-Seq_U87_Human | 1.15375074 |
77 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.14888614 |
78 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.13513968 |
79 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.13462334 |
80 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.13353469 |
81 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.12876896 |
82 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.12633013 |
83 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.12141692 |
84 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.11700839 |
85 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.11700839 |
86 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.10656092 |
87 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.10318920 |
88 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.09837806 |
89 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.09248000 |
90 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.08508497 |
91 | KDM2B_26808549_Chip-Seq_REH_Human | 1.08190455 |
92 | VDR_22108803_ChIP-Seq_LS180_Human | 1.07971362 |
93 | * UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.07573703 |
94 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.07170746 |
95 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.06998019 |
96 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.06470442 |
97 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.05984044 |
98 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.05984044 |
99 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 1.05404836 |
100 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 1.05107864 |
101 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.04842936 |
102 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.04480042 |
103 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.04405758 |
104 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.03978453 |
105 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.03419206 |
106 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.01933942 |
107 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.01892060 |
108 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.01556673 |
109 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.99850550 |
110 | TP53_16413492_ChIP-PET_HCT116_Human | 0.99173986 |
111 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.97738812 |
112 | JUN_21703547_ChIP-Seq_K562_Human | 0.97405702 |
113 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.96927627 |
114 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.95347636 |
115 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.93382392 |
116 | * TP53_18474530_ChIP-ChIP_U2OS_Human | 0.92950000 |
117 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.92745224 |
118 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.92691908 |
119 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.91179813 |
120 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.89877886 |
121 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.88906001 |
122 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.88267476 |
123 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.85329565 |
124 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.84910347 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0004859_abnormal_synaptic_plasticity | 5.89794271 |
2 | MP0003880_abnormal_central_pattern | 4.97045151 |
3 | MP0003635_abnormal_synaptic_transmissio | 4.01648466 |
4 | MP0004270_analgesia | 3.67874639 |
5 | MP0009745_abnormal_behavioral_response | 3.37748799 |
6 | MP0002063_abnormal_learning/memory/cond | 3.25601109 |
7 | MP0002064_seizures | 3.08259074 |
8 | MP0001968_abnormal_touch/_nociception | 3.04883946 |
9 | MP0009046_muscle_twitch | 3.02493358 |
10 | MP0002572_abnormal_emotion/affect_behav | 2.78784648 |
11 | MP0002822_catalepsy | 2.78283192 |
12 | MP0002734_abnormal_mechanical_nocicepti | 2.61472446 |
13 | MP0002272_abnormal_nervous_system | 2.56730836 |
14 | MP0002736_abnormal_nociception_after | 2.45036817 |
15 | MP0002735_abnormal_chemical_nociception | 2.39552138 |
16 | MP0001486_abnormal_startle_reflex | 2.38375401 |
17 | MP0001501_abnormal_sleep_pattern | 2.33908233 |
18 | MP0005423_abnormal_somatic_nervous | 2.32117268 |
19 | MP0001440_abnormal_grooming_behavior | 2.19040872 |
20 | MP0009780_abnormal_chondrocyte_physiolo | 2.16747836 |
21 | MP0002733_abnormal_thermal_nociception | 2.06517947 |
22 | MP0001970_abnormal_pain_threshold | 1.99960468 |
23 | MP0006276_abnormal_autonomic_nervous | 1.98060457 |
24 | MP0002067_abnormal_sensory_capabilities | 1.96972323 |
25 | MP0002909_abnormal_adrenal_gland | 1.87739305 |
26 | MP0003329_amyloid_beta_deposits | 1.84188804 |
27 | MP0002184_abnormal_innervation | 1.79711826 |
28 | MP0002837_dystrophic_cardiac_calcinosis | 1.79194638 |
29 | MP0004924_abnormal_behavior | 1.78197114 |
30 | MP0005386_behavior/neurological_phenoty | 1.78197114 |
31 | MP0008569_lethality_at_weaning | 1.70809058 |
32 | MP0000778_abnormal_nervous_system | 1.69952894 |
33 | MP0002557_abnormal_social/conspecific_i | 1.68494984 |
34 | MP0005646_abnormal_pituitary_gland | 1.65775623 |
35 | MP0001529_abnormal_vocalization | 1.63467463 |
36 | MP0004811_abnormal_neuron_physiology | 1.61230703 |
37 | MP0003121_genomic_imprinting | 1.59166689 |
38 | MP0004858_abnormal_nervous_system | 1.57975774 |
39 | MP0001984_abnormal_olfaction | 1.54927719 |
40 | MP0003122_maternal_imprinting | 1.54706651 |
41 | MP0010386_abnormal_urinary_bladder | 1.54070652 |
42 | MP0003787_abnormal_imprinting | 1.48518254 |
43 | MP0000013_abnormal_adipose_tissue | 1.46060344 |
44 | MP0000955_abnormal_spinal_cord | 1.45392332 |
45 | MP0003879_abnormal_hair_cell | 1.43902635 |
46 | MP0002066_abnormal_motor_capabilities/c | 1.37137417 |
47 | MP0001905_abnormal_dopamine_level | 1.37111671 |
48 | MP0005645_abnormal_hypothalamus_physiol | 1.34689377 |
49 | MP0001188_hyperpigmentation | 1.33697497 |
50 | MP0004145_abnormal_muscle_electrophysio | 1.32685547 |
51 | MP0002882_abnormal_neuron_morphology | 1.32246501 |
52 | MP0000751_myopathy | 1.31316533 |
53 | MP0008877_abnormal_DNA_methylation | 1.27346026 |
54 | MP0003633_abnormal_nervous_system | 1.25022189 |
55 | MP0004142_abnormal_muscle_tone | 1.16317580 |
56 | MP0005248_abnormal_Harderian_gland | 1.16280313 |
57 | MP0004885_abnormal_endolymph | 1.14471272 |
58 | MP0001502_abnormal_circadian_rhythm | 1.14359656 |
59 | MP0003631_nervous_system_phenotype | 1.04381877 |
60 | MP0002152_abnormal_brain_morphology | 0.99919496 |
61 | MP0004215_abnormal_myocardial_fiber | 0.97989109 |
62 | MP0004085_abnormal_heartbeat | 0.97866095 |
63 | MP0005535_abnormal_body_temperature | 0.94907515 |
64 | MP0008872_abnormal_physiological_respon | 0.91544043 |
65 | MP0002069_abnormal_eating/drinking_beha | 0.91230612 |
66 | MP0002229_neurodegeneration | 0.90991203 |
67 | MP0004484_altered_response_of | 0.88856266 |
68 | MP0005551_abnormal_eye_electrophysiolog | 0.87042500 |
69 | MP0002876_abnormal_thyroid_physiology | 0.83993213 |
70 | MP0008874_decreased_physiological_sensi | 0.83752374 |
71 | MP0001177_atelectasis | 0.82212386 |
72 | MP0004742_abnormal_vestibular_system | 0.81943836 |
73 | MP0003283_abnormal_digestive_organ | 0.80595241 |
74 | MP0001986_abnormal_taste_sensitivity | 0.78795107 |
75 | MP0000604_amyloidosis | 0.77885623 |
76 | MP0003634_abnormal_glial_cell | 0.77609459 |
77 | MP0001963_abnormal_hearing_physiology | 0.75478318 |
78 | MP0000631_abnormal_neuroendocrine_gland | 0.74069183 |
79 | MP0005253_abnormal_eye_physiology | 0.73269213 |
80 | MP0004233_abnormal_muscle_weight | 0.72034203 |
81 | MP0004043_abnormal_pH_regulation | 0.71399915 |
82 | MP0003632_abnormal_nervous_system | 0.70609693 |
83 | MP0005394_taste/olfaction_phenotype | 0.70374197 |
84 | MP0005499_abnormal_olfactory_system | 0.70374197 |
85 | MP0003137_abnormal_impulse_conducting | 0.68562848 |
86 | MP0001664_abnormal_digestion | 0.68359714 |
87 | MP0002752_abnormal_somatic_nervous | 0.68352659 |
88 | MP0002102_abnormal_ear_morphology | 0.67494364 |
89 | MP0005623_abnormal_meninges_morphology | 0.66465678 |
90 | MP0000569_abnormal_digit_pigmentation | 0.65208281 |
91 | MP0003861_abnormal_nervous_system | 0.65081738 |
92 | MP0002090_abnormal_vision | 0.64885194 |
93 | MP0008961_abnormal_basal_metabolism | 0.64107012 |
94 | MP0001299_abnormal_eye_distance/ | 0.63569245 |
95 | MP0004036_abnormal_muscle_relaxation | 0.63099733 |
96 | MP0002638_abnormal_pupillary_reflex | 0.62405919 |
97 | MP0000920_abnormal_myelination | 0.61410006 |
98 | MP0005171_absent_coat_pigmentation | 0.61080405 |
99 | MP0003690_abnormal_glial_cell | 0.60734125 |
100 | MP0003123_paternal_imprinting | 0.58444221 |
101 | MP0005409_darkened_coat_color | 0.58272704 |
102 | MP0001943_abnormal_respiration | 0.58094374 |
103 | MP0005620_abnormal_muscle_contractility | 0.57590919 |
104 | MP0010770_preweaning_lethality | 0.56954719 |
105 | MP0002082_postnatal_lethality | 0.56954719 |
106 | MP0002133_abnormal_respiratory_system | 0.56678468 |
107 | MP0005388_respiratory_system_phenotype | 0.56678468 |
108 | MP0010769_abnormal_survival | 0.56603621 |
109 | MP0005187_abnormal_penis_morphology | 0.56598670 |
110 | MP0000639_abnormal_adrenal_gland | 0.55723131 |
111 | MP0006072_abnormal_retinal_apoptosis | 0.55224144 |
112 | MP0003385_abnormal_body_wall | 0.54016588 |
113 | MP0004130_abnormal_muscle_cell | 0.53481163 |
114 | MP0000747_muscle_weakness | 0.53237228 |
115 | MP0000534_abnormal_ureter_morphology | 0.53211713 |
116 | MP0003075_altered_response_to | 0.53169306 |
117 | MP0001485_abnormal_pinna_reflex | 0.52109817 |
118 | MP0002234_abnormal_pharynx_morphology | 0.51280416 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Focal motor seizures (HP:0011153) | 7.72659569 |
2 | Myokymia (HP:0002411) | 6.17016017 |
3 | Focal seizures (HP:0007359) | 5.62031086 |
4 | Visual hallucinations (HP:0002367) | 5.13944268 |
5 | Atonic seizures (HP:0010819) | 5.07490018 |
6 | Epileptic encephalopathy (HP:0200134) | 4.77409814 |
7 | Febrile seizures (HP:0002373) | 4.43669747 |
8 | Absence seizures (HP:0002121) | 4.38679620 |
9 | Progressive cerebellar ataxia (HP:0002073) | 4.14940368 |
10 | Dialeptic seizures (HP:0011146) | 3.94730065 |
11 | Generalized tonic-clonic seizures (HP:0002069) | 3.88662838 |
12 | Hyperventilation (HP:0002883) | 3.68636924 |
13 | Action tremor (HP:0002345) | 3.63341059 |
14 | Broad-based gait (HP:0002136) | 3.49344768 |
15 | Papillary thyroid carcinoma (HP:0002895) | 3.36073106 |
16 | Supranuclear gaze palsy (HP:0000605) | 3.34686320 |
17 | Poor eye contact (HP:0000817) | 3.16560373 |
18 | Depression (HP:0000716) | 3.13815944 |
19 | Anxiety (HP:0000739) | 3.13126573 |
20 | Truncal ataxia (HP:0002078) | 3.12270950 |
21 | Gaze-evoked nystagmus (HP:0000640) | 3.09643617 |
22 | Amblyopia (HP:0000646) | 3.03210313 |
23 | Pheochromocytoma (HP:0002666) | 3.02671009 |
24 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.00044730 |
25 | Dysdiadochokinesis (HP:0002075) | 2.98868185 |
26 | Ankle clonus (HP:0011448) | 2.97120829 |
27 | Abnormal social behavior (HP:0012433) | 2.88429452 |
28 | Impaired social interactions (HP:0000735) | 2.88429452 |
29 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.83957090 |
30 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.83957090 |
31 | Dysmetria (HP:0001310) | 2.83024611 |
32 | Abnormal eating behavior (HP:0100738) | 2.82238384 |
33 | Progressive inability to walk (HP:0002505) | 2.76235137 |
34 | Cerebral inclusion bodies (HP:0100314) | 2.75298696 |
35 | Excessive salivation (HP:0003781) | 2.72531159 |
36 | Drooling (HP:0002307) | 2.72531159 |
37 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.69669735 |
38 | Papilledema (HP:0001085) | 2.69421982 |
39 | Neuroendocrine neoplasm (HP:0100634) | 2.66578373 |
40 | Insidious onset (HP:0003587) | 2.63938114 |
41 | Termporal pattern (HP:0011008) | 2.63938114 |
42 | Epileptiform EEG discharges (HP:0011182) | 2.60658093 |
43 | Limb dystonia (HP:0002451) | 2.57665754 |
44 | Scanning speech (HP:0002168) | 2.57103887 |
45 | Neurofibrillary tangles (HP:0002185) | 2.55904863 |
46 | Mutism (HP:0002300) | 2.53537215 |
47 | Postural instability (HP:0002172) | 2.48079457 |
48 | Urinary urgency (HP:0000012) | 2.47820110 |
49 | EEG with generalized epileptiform discharges (HP:0011198) | 2.46045328 |
50 | Diplopia (HP:0000651) | 2.45341171 |
51 | Abnormality of binocular vision (HP:0011514) | 2.45341171 |
52 | Impaired smooth pursuit (HP:0007772) | 2.44348150 |
53 | Hemiparesis (HP:0001269) | 2.42963849 |
54 | Genetic anticipation (HP:0003743) | 2.42776807 |
55 | Abnormality of the lower motor neuron (HP:0002366) | 2.39047900 |
56 | Torticollis (HP:0000473) | 2.36538466 |
57 | Fetal akinesia sequence (HP:0001989) | 2.35086477 |
58 | Bradykinesia (HP:0002067) | 2.34045245 |
59 | Hypsarrhythmia (HP:0002521) | 2.29965642 |
60 | Absent speech (HP:0001344) | 2.25483298 |
61 | Focal dystonia (HP:0004373) | 2.24867133 |
62 | Hammertoe (HP:0001765) | 2.24190121 |
63 | Stereotypic behavior (HP:0000733) | 2.24172743 |
64 | Inability to walk (HP:0002540) | 2.21781569 |
65 | Spastic gait (HP:0002064) | 2.21380410 |
66 | Agitation (HP:0000713) | 2.20175709 |
67 | Thyroid carcinoma (HP:0002890) | 2.20006406 |
68 | Dysmetric saccades (HP:0000641) | 2.17519334 |
69 | Polyphagia (HP:0002591) | 2.15597238 |
70 | Abnormality of the corticospinal tract (HP:0002492) | 2.14310068 |
71 | Blue irides (HP:0000635) | 2.11772841 |
72 | Morphological abnormality of the pyramidal tract (HP:0002062) | 2.11473017 |
73 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.09206787 |
74 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 2.07584346 |
75 | Megalencephaly (HP:0001355) | 2.06877117 |
76 | Intention tremor (HP:0002080) | 2.05765127 |
77 | Peripheral hypomyelination (HP:0007182) | 2.05560949 |
78 | Lower limb muscle weakness (HP:0007340) | 2.04408044 |
79 | Gait imbalance (HP:0002141) | 2.03766363 |
80 | Status epilepticus (HP:0002133) | 2.03400283 |
81 | Clonus (HP:0002169) | 2.03033007 |
82 | Thickened helices (HP:0000391) | 2.02316688 |
83 | Craniofacial dystonia (HP:0012179) | 2.02147053 |
84 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.00701316 |
85 | Spastic tetraplegia (HP:0002510) | 2.00358245 |
86 | Generalized myoclonic seizures (HP:0002123) | 2.00076209 |
87 | Failure to thrive in infancy (HP:0001531) | 1.99976974 |
88 | Hypoventilation (HP:0002791) | 1.99032292 |
89 | Impaired vibratory sensation (HP:0002495) | 1.98730325 |
90 | Resting tremor (HP:0002322) | 1.97183754 |
91 | Ventricular fibrillation (HP:0001663) | 1.96920700 |
92 | Amyotrophic lateral sclerosis (HP:0007354) | 1.95994458 |
93 | Neoplasm of the peripheral nervous system (HP:0100007) | 1.95687724 |
94 | Tetraplegia (HP:0002445) | 1.94006272 |
95 | Gait ataxia (HP:0002066) | 1.93783694 |
96 | Sleep apnea (HP:0010535) | 1.93755756 |
97 | Protruding tongue (HP:0010808) | 1.92928904 |
98 | Hypoplasia of the corpus callosum (HP:0002079) | 1.91286385 |
99 | Paraplegia (HP:0010550) | 1.90839170 |
100 | Psychosis (HP:0000709) | 1.89821817 |
101 | Delusions (HP:0000746) | 1.89606908 |
102 | Hemiplegia (HP:0002301) | 1.89193015 |
103 | Spastic paraplegia (HP:0001258) | 1.85695045 |
104 | Inappropriate behavior (HP:0000719) | 1.82968027 |
105 | Split foot (HP:0001839) | 1.82604039 |
106 | Rapidly progressive (HP:0003678) | 1.81743755 |
107 | Decreased number of peripheral myelinated nerve fibers (HP:0003380) | 1.81569929 |
108 | Abnormality of salivation (HP:0100755) | 1.81346533 |
109 | Incomplete penetrance (HP:0003829) | 1.80204888 |
110 | Congenital primary aphakia (HP:0007707) | 1.77878014 |
111 | Neuronal loss in central nervous system (HP:0002529) | 1.77554265 |
112 | Hyperthyroidism (HP:0000836) | 1.74512010 |
113 | Menstrual irregularities (HP:0000858) | 1.73803959 |
114 | Ulnar claw (HP:0001178) | 1.73515196 |
115 | Impaired pain sensation (HP:0007328) | 1.73249615 |
116 | Abnormality of pain sensation (HP:0010832) | 1.73249615 |
117 | Specific learning disability (HP:0001328) | 1.72964082 |
118 | Akinesia (HP:0002304) | 1.71855314 |
119 | Abnormal EKG (HP:0003115) | 1.71730125 |
120 | Exercise-induced muscle cramps (HP:0003710) | 1.71022032 |
121 | Obstructive sleep apnea (HP:0002870) | 1.70840242 |
122 | Lower limb asymmetry (HP:0100559) | 1.70813413 |
123 | Heterochromia iridis (HP:0001100) | 1.70697673 |
124 | Hepatoblastoma (HP:0002884) | 1.70318405 |
125 | Postural tremor (HP:0002174) | 1.69250368 |
126 | Rigidity (HP:0002063) | 1.69085123 |
Rank | Gene Set | Z-score |
---|---|---|
1 | NTRK3 | 4.48393627 |
2 | EPHA4 | 4.22685769 |
3 | MAP3K9 | 3.45129138 |
4 | MAP3K4 | 3.13472010 |
5 | MARK1 | 2.76455245 |
6 | MAP2K7 | 2.74527349 |
7 | MAP3K12 | 2.68455645 |
8 | MINK1 | 2.65936804 |
9 | CASK | 2.48536594 |
10 | RIPK4 | 2.36469162 |
11 | DAPK2 | 2.23848517 |
12 | MAP2K4 | 2.11928782 |
13 | KSR2 | 2.08478388 |
14 | NTRK1 | 2.01342496 |
15 | ERBB3 | 1.84692730 |
16 | PAK6 | 1.80416254 |
17 | PNCK | 1.73546888 |
18 | NTRK2 | 1.71471805 |
19 | PLK2 | 1.70571626 |
20 | KSR1 | 1.62143575 |
21 | PRKD3 | 1.57402666 |
22 | DAPK1 | 1.54568088 |
23 | ARAF | 1.54321700 |
24 | GRK5 | 1.51881694 |
25 | CAMKK1 | 1.51424343 |
26 | CDK5 | 1.48814535 |
27 | EPHA3 | 1.38835478 |
28 | TNIK | 1.33713990 |
29 | MAP3K2 | 1.30882817 |
30 | CDK19 | 1.30180484 |
31 | MAPK13 | 1.24257546 |
32 | PRKCG | 1.21068942 |
33 | CAMKK2 | 1.17680141 |
34 | FRK | 1.14814577 |
35 | STK38 | 1.11396926 |
36 | CAMK2A | 1.09890455 |
37 | PRPF4B | 1.07621305 |
38 | MAP3K13 | 1.07604004 |
39 | BMPR2 | 1.07129349 |
40 | SIK2 | 1.06043837 |
41 | FES | 1.05815391 |
42 | PHKG1 | 1.02870041 |
43 | PHKG2 | 1.02870041 |
44 | UHMK1 | 1.02197791 |
45 | TRIM28 | 1.01609885 |
46 | PTK2B | 1.00765823 |
47 | FGFR2 | 0.95187348 |
48 | CAMK2B | 0.93890566 |
49 | SGK223 | 0.91376679 |
50 | SGK494 | 0.91376679 |
51 | BRD4 | 0.90690936 |
52 | LATS2 | 0.88895148 |
53 | RET | 0.88358266 |
54 | PAK3 | 0.84718990 |
55 | CDK18 | 0.83427215 |
56 | OXSR1 | 0.83014097 |
57 | CDK14 | 0.82554719 |
58 | NEK6 | 0.82155288 |
59 | CDK15 | 0.79898123 |
60 | SGK2 | 0.79728543 |
61 | CSNK1A1L | 0.78964631 |
62 | RAF1 | 0.78559836 |
63 | NME1 | 0.78231661 |
64 | LMTK2 | 0.76228277 |
65 | TYRO3 | 0.76012846 |
66 | CAMK1 | 0.75792681 |
67 | STK38L | 0.74517513 |
68 | PRKCH | 0.73738451 |
69 | MAP3K6 | 0.73730175 |
70 | FER | 0.73714282 |
71 | AKT3 | 0.73058706 |
72 | MAP3K1 | 0.72570296 |
73 | YES1 | 0.68964634 |
74 | CSNK1G3 | 0.68125217 |
75 | CSNK1G2 | 0.68112094 |
76 | SGK1 | 0.67785056 |
77 | PRKCE | 0.67635607 |
78 | CDK11A | 0.67583691 |
79 | STK11 | 0.67400393 |
80 | CSNK1G1 | 0.66869773 |
81 | DYRK1A | 0.65336946 |
82 | CAMK2D | 0.64058229 |
83 | PINK1 | 0.62950832 |
84 | SGK3 | 0.61658275 |
85 | MAP4K2 | 0.60880330 |
86 | PKN1 | 0.59040447 |
87 | BMPR1B | 0.56995836 |
88 | CAMK4 | 0.56348600 |
89 | MAP2K1 | 0.56177289 |
90 | TAOK1 | 0.55593235 |
91 | CCNB1 | 0.55049414 |
92 | PDPK1 | 0.54899318 |
93 | PDK1 | 0.53952491 |
94 | PDGFRA | 0.53472403 |
95 | WNK1 | 0.53466186 |
96 | FGR | 0.52234037 |
97 | WNK3 | 0.52045355 |
98 | FGFR3 | 0.51913204 |
99 | PDK3 | 0.51667721 |
100 | PDK4 | 0.51667721 |
101 | TNK2 | 0.50103114 |
102 | CAMK2G | 0.49575251 |
103 | DYRK1B | 0.48174727 |
104 | MARK2 | 0.46783153 |
105 | DYRK2 | 0.46617423 |
106 | MAP3K5 | 0.46288884 |
107 | CAMK1G | 0.45820038 |
108 | SCYL2 | 0.45429829 |
109 | GRK7 | 0.44878463 |
110 | JAK1 | 0.44845478 |
111 | WNK4 | 0.44550562 |
112 | PRKCZ | 0.44185585 |
113 | RPS6KA3 | 0.43880479 |
114 | PDGFRB | 0.42946381 |
115 | ROCK2 | 0.42721358 |
116 | PRKG1 | 0.42656610 |
117 | DMPK | 0.42014604 |
118 | CDC42BPA | 0.41709825 |
119 | ERBB2 | 0.41389157 |
120 | ROCK1 | 0.40585767 |
121 | BRAF | 0.40219875 |
122 | FYN | 0.40200932 |
123 | BCR | 0.39747744 |
124 | SIK3 | 0.39567138 |
125 | MAPK10 | 0.38798024 |
126 | DAPK3 | 0.34665386 |
127 | RPS6KA2 | 0.33636121 |
128 | STK39 | 0.32890122 |
129 | ADRBK1 | 0.32577364 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.67622366 |
2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.24232679 |
3 | Long-term potentiation_Homo sapiens_hsa04720 | 2.73009073 |
4 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.68769462 |
5 | GABAergic synapse_Homo sapiens_hsa04727 | 2.63633212 |
6 | Circadian entrainment_Homo sapiens_hsa04713 | 2.62243264 |
7 | Olfactory transduction_Homo sapiens_hsa04740 | 2.57212075 |
8 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.53169794 |
9 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.43333586 |
10 | Morphine addiction_Homo sapiens_hsa05032 | 2.42707851 |
11 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.21651076 |
12 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.15689059 |
13 | Salivary secretion_Homo sapiens_hsa04970 | 2.09836896 |
14 | Insulin secretion_Homo sapiens_hsa04911 | 2.04018601 |
15 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.90646676 |
16 | Renin secretion_Homo sapiens_hsa04924 | 1.87220126 |
17 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.83983715 |
18 | Taste transduction_Homo sapiens_hsa04742 | 1.83820985 |
19 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.82969363 |
20 | Long-term depression_Homo sapiens_hsa04730 | 1.76913175 |
21 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.76095379 |
22 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.72444080 |
23 | Cocaine addiction_Homo sapiens_hsa05030 | 1.65467847 |
24 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.62011322 |
25 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.61841609 |
26 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.58316145 |
27 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.57402742 |
28 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.42272971 |
29 | Gap junction_Homo sapiens_hsa04540 | 1.33761741 |
30 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.30149890 |
31 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.25589566 |
32 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.24348930 |
33 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.20795637 |
34 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.19489444 |
35 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.15387402 |
36 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.12256513 |
37 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.08056255 |
38 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.07708134 |
39 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.06743867 |
40 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.06573137 |
41 | Glioma_Homo sapiens_hsa05214 | 1.05146035 |
42 | Melanogenesis_Homo sapiens_hsa04916 | 1.02624949 |
43 | Axon guidance_Homo sapiens_hsa04360 | 1.01805483 |
44 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.99005880 |
45 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.98568698 |
46 | Phototransduction_Homo sapiens_hsa04744 | 0.91055557 |
47 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.90396878 |
48 | Alzheimers disease_Homo sapiens_hsa05010 | 0.88599088 |
49 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.86970717 |
50 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.86340382 |
51 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.85746820 |
52 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.82264425 |
53 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.81548918 |
54 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.81546075 |
55 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.80456168 |
56 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.76182732 |
57 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.72964574 |
58 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.71611625 |
59 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.70796808 |
60 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.70220636 |
61 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.70116565 |
62 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.67173035 |
63 | Parkinsons disease_Homo sapiens_hsa05012 | 0.64758551 |
64 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.63433252 |
65 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.63327668 |
66 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.62935206 |
67 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.59352268 |
68 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.56676818 |
69 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.56283634 |
70 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.56226969 |
71 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.54504920 |
72 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.53905054 |
73 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.53396183 |
74 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.53046854 |
75 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.52656196 |
76 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.51234508 |
77 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.49504914 |
78 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.49216938 |
79 | Adherens junction_Homo sapiens_hsa04520 | 0.49014757 |
80 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.48806141 |
81 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.48249601 |
82 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.48223248 |
83 | Colorectal cancer_Homo sapiens_hsa05210 | 0.47504666 |
84 | Alcoholism_Homo sapiens_hsa05034 | 0.47466168 |
85 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.45101245 |
86 | Prion diseases_Homo sapiens_hsa05020 | 0.44078993 |
87 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.43541783 |
88 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.43296367 |
89 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.43127361 |
90 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.42036837 |
91 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.41405112 |
92 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.41190064 |
93 | Circadian rhythm_Homo sapiens_hsa04710 | 0.41136373 |
94 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.40028820 |
95 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.38671613 |
96 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.38534912 |
97 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.38433280 |
98 | Tight junction_Homo sapiens_hsa04530 | 0.38430804 |
99 | Endocytosis_Homo sapiens_hsa04144 | 0.38264811 |
100 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.37936146 |
101 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.36848499 |
102 | Huntingtons disease_Homo sapiens_hsa05016 | 0.36755145 |
103 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.36659554 |
104 | Endometrial cancer_Homo sapiens_hsa05213 | 0.36195547 |
105 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.36008310 |
106 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.35711210 |
107 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.35340061 |
108 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.34946328 |
109 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.34639329 |
110 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.34320286 |
111 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.34282968 |
112 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.34136543 |
113 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.33999527 |
114 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.33181972 |
115 | Bile secretion_Homo sapiens_hsa04976 | 0.32474703 |
116 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.32387950 |
117 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.32063916 |
118 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.32008497 |